Eskenazi Sarah, Bachelot Anne, Hugon-Rodin Justine, Plu-Bureau Genevieve, Gompel Anne, Catteau-Jonard Sophie, Molina-Gomes Denise, Dewailly Didier, Dodé Catherine, Christin-Maitre Sophie, Touraine Philippe
Department of Reproductive Endocrinology, Saint-Antoine Hospital, AP-HP, Paris, France; Center for Rare Growth Disorders and Center for Developmental Disorders: CMERC.
Sorbonne University Medicine, Paris, France.
J Endocr Soc. 2021 Mar 1;5(7):bvab032. doi: 10.1210/jendso/bvab032. eCollection 2021 Jul 1.
Primary ovarian insufficiency (POI) affects 1% of women under 40 years of age. POI is idiopathic in more than 70% of cases. Though many candidate genes have been identified in recent years, the prevalence and pathogenicity of abnormalities are still difficult to establish.
Our primary objective was to evaluate the prevalence of gene variations in a large prospective multicentric POI cohort. Our secondary objective was to evaluate the correlation between phenotype and genotype.
Two hundred and sixty-nine well-phenotyped POI patients were screened for variants of 18 known POI genes (, , , , , , , , , , , , , , , , , and by next generation sequencing (NGS). Abnormalities were classified as "variant" or "variant of unknown signification" (VUS) according to available functional tests or algorithms (SIFT, Polyphen-2, MutationTaster).
One hundred and two patients (38%) were identified as having at least 1 genetic abnormality. Sixty-seven patients (25%) presented at least 1 variant. Forty-eight patients presented at least 1 VUS (18%). Thirteen patients (5%) had combined abnormalities. variants were the most common gene variants involved in POI (9%). Interestingly, we saw no significant differences in the previous family history of POI, ethnic origin, age at onset of POI, primary amenorrhea, or secondary menstrual disturbances between the different genotypes.
In our study, a high percentage of patients presented gene variants detected by NGS analysis (38%). Every POI patient should undergo NGS analysis to improve medical cares of the patients.
原发性卵巢功能不全(POI)影响1%的40岁以下女性。超过70%的POI病例为特发性。尽管近年来已鉴定出许多候选基因,但异常的患病率和致病性仍难以确定。
我们的主要目的是评估一个大型前瞻性多中心POI队列中基因变异的患病率。我们的次要目的是评估表型与基因型之间的相关性。
通过下一代测序(NGS)对269例表型良好的POI患者进行18个已知POI基因(、、、、、、、、、、、、、、、、和)变异的筛查。根据可用的功能测试或算法(SIFT、Polyphen-2、MutationTaster),将异常分类为“变异”或“意义未明的变异”(VUS)。
102例患者(38%)被鉴定为至少有1种基因异常。67例患者(25%)出现至少1种变异。48例患者出现至少1种VUS(18%)。13例患者(5%)有合并异常。变异是POI中最常见的基因变异(9%)。有趣的是,我们发现在不同基因型之间,POI的既往家族史、种族、POI发病年龄、原发性闭经或继发性月经紊乱方面没有显著差异。
在我们的研究中,高比例患者通过NGS分析检测到基因变异(38%)。每例POI患者都应接受NGS分析以改善患者的医疗护理。